步长制药: 山东步长制药股份有限公司关于投资基金拟减资暨公司出资比例变更的公告

Group 1 - The company, Shandong Buchang Pharmaceutical Co., Ltd., is participating as a limited partner in the investment fund Hainan Sanya Yuhai Growth Equity Investment Fund Partnership, which is undergoing a capital reduction due to the withdrawal of its limited partner, Green Leaf Investment Group [1][3] - Following the withdrawal of Green Leaf Investment Group and the completion of the capital reduction, the total capital of Hainan Sanya Yuhai will decrease from 614.50 million to 514.50 million, while the company's subscribed capital remains unchanged, resulting in an increase in its ownership percentage from 16.2734% to 19.4363% [1][3] - The board of directors approved the capital reduction proposal on July 8, 2025, and this matter does not require approval from the shareholders' meeting [2][3] Group 2 - The capital reduction does not constitute a related party transaction and does not fall under the category of significant asset restructuring as defined by the regulations [2][3] - The financial data of Hainan Sanya Yuhai as of December 31, 2024, shows total assets of 238.22 million, total liabilities of 1.25 million, and a net asset of 238.09 million, with a net profit of -9.21 million for the year [2] - As of March 31, 2025, the fund's total assets were 235.79 million, total liabilities were 0.64 million, and net assets were 235.79 million, with a net profit of -0.23 million for the first quarter of 2025 [2][4]